|
|
 |
|
Viewing report
|
|
|
|
An Evaluation of Product Usage for Molecular Testing within Infectious Diseases - Europe
HBS Consulting, Aug 2004
The new report examines the reality of 221 laboratories and hospitals in 11 European countries and provides you with following information:
Molecular Tests
- Description of laboratory landscape per country
- the number of performed tests for 47 pathogens
- which products, technologies and manufacturers are used per pathogen
- determine current laboratory equipment that is used for microbiology testing
- Unmet needs
- which tests, technologies and products show the most promising market opportunities in the short tmedium term
- market potential in volume per test, technology and country
- regulatory issues per country (legislation, reimbursement
Product Value Proposition
The study will allow the owner of the information to:
- Assess current market realities in terms of currently performed tests / Used technologies at an unparalleled level of segmentation
- Get detailed knowledge on suppliers of molecular test kits / equipment, (by segmentation criteria)
- Reflect the current situation not only at a specific point in time, but monitor trends over a period of time (both in terms of market participants as well as system types)
- Model market and own sales forecasts on system types based on investment plans of customers
- Reflect the expected behaviour of buyers, not just the expectations of sellers; but by the motivations of buyers.
- Model market forecasts on associated product lines (e.g. PCR Cycler, NAT related devices) based on procedure data
- Make decisions regarding the market entry/marketing strategy
Respondents have been chosen randomly in order to guarantee that the respondents reflect the real market situation. However the definition of the project required the focus on such institutions that perform molecular testing particularly.
Segmentation by Indication
- STD
Chlamydia trachomatis
Neisseria gonorrhoeae
HIV
HCV
- Mycobacteria
Mycobacterium tuberculosis
Mycobacterium avium
- Atypical Pneumoniae
Bordetella sp.
Legionella pneumophilia
Chlamydia sp.
Mycoplasma pneumoniae
- CMV
quantitative
qualitative
- Virale Meningitis/Encephalitis
HSV 1,2
Enterovirus
West Nile Virus
- Respiratory Virus
SARS
Adenovirus
Influenza A
Influenza A and B
RSV
Parainfluenza
- HPV
- Chronic Meningitis
Blastomyces
Histoplasma
Cryptococcus
Coccidioides
TB
- Bacterial Meningitis
Neisseria meningitidis
Haemophilus
Pneumokokken
Listeria
Enterobacteriacea/Nonfermentors
- Tick Born Encephalitis
RMSF
Babesia
Ehrlichia
Anaplasma
Borrelia
- MRSA
- Fungi
Segmentation by Technology
- commercial available tests with amplification (methods: PCR, LCR, SDA)
- Commercial tests without amplification (method: DNA probes)
- Others: EIA (enzyme linked tests), Antibody/Antigencomplex tests, serology, microscopy, strip tests
Segmentation by Country
- Germany
- UK
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Finland
- Belgium
- Switzerland
We also provide this Evaluation of Product Usage for Molecular Testing within Infectious Diseases for individual countries and groups of countries. Please request more information by clicking ' Enquire Before Buying' at the top left side of this description.
Customers who bought this item also bought
An Evaluation of Product Usage for Molecular Testing within Infectious Diseases - Norway, Denmark, Sweden, Finland, Belgium and Switzerland
An Evaluation of Product Usage for Molecular Testing within Infectious Diseases - Germany, France, Italy, UK & Spain
Automated and Rapid Microbiological Tests - Global Strategic Business Report
Molecular Diagnostics Markets
Molecular Diagnostics - Technologies, Markets and Companies
Cytology and HPV Testing World Markets
Worldwide Clinical Laboratory Testing Market
Molecular Diagnostics - An In-Depth Survey of the US Molecular Diagnostic Laboratories By Enterprise Analysis Corporation
The Emerging European Molecular POC Testing Markets
Point of Care Diagnostic Testing World Markets
Molecular Diagnostics - Global Strategic Business Report
Biomarkers and Tests for Pharma/ Biotech R&D � Companies Products and WW Market, 2006-2011
|
|
|
|
